Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 4/20 | 0.39 |
| ▸ | CES2 | O00748 | 3/20 | 0.38 |
| ▸ | CES1 | P23141 | 3/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17090824 | 1.00 | TSHR (0.47) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL17090807 | 1.00 | TSHR (0.47) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL17090815 | 1.00 | TSHR (0.47) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL17090809 | 1.00 | TSHR (0.47) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL1494494 | 1.00 | TSHR (0.47) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL17090822 | 1.00 | TSHR (0.47) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL2804365 | 1.00 | TSHR (0.47) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL17090765 | 1.00 | TSHR (0.47) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL17090838 | 1.00 | TSHR (0.47) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL1494268 | 1.00 | TSHR (0.47) | TSHRTHRBEPHX1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10854818-B2 | Dendrimer compound and organic luminescent device employing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-12-01 | — | — | US | disclosed |
| CN-106146851-B | Photocurable composition and cured product containing same | 信越化学工业株式会社 | 2020-10-23 | — | — | CN | disclosed |
| US-10730904-B2 | Method for liquid-phase synthesis of nucleic acid | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2020-08-04 | — | — | US | disclosed |
| EP-2921499-B1 | METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACIDS | TAKEDA PHARMACEUTICALS CO (JP) | 2020-01-22 | — | — | EP | disclosed |
| EP-3093303-B1 | PHOTOCURABLE COMPOSITION AND CURED PRODUCT | SHINETSU CHEMICAL CO (JP) | 2019-08-28 | — | — | EP | disclosed |
| US-20190135852-A1 | METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACID | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2019-05-09 | — | — | US | disclosed |
| US-20180138413-A1 | DENDRIMER COMPOUND AND ORGANIC LUMINESCENT DEVICE EMPLOYING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-17 | — | — | US | disclosed |
| US-9966532-B2 | Dendrimer compound and organic luminescent device employing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-08 | — | — | US | disclosed |
| US-9735374-B2 | Metal complex and light-emitting device containing the metal complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-08-15 | — | — | US | disclosed |
| US-9705097-B2 | Metal complex and light-emitting device containing the metal complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-07-11 | — | — | US | disclosed |
| US-20100019669-A1 | METAL COMPLEX, POLYMER COMPOUND AND DEVICE CONTAINING THOSE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-01-28 | — | — | US | disclosed |
| EP-2128168-A1 | METAL COMPLEX, POLYMER COMPOUND AND DEVICE CONTAINING THOSE | Sumitomo Chemical Company, Limited (JP) | 2009-12-02 | — | — | EP | disclosed |
| US-20090043064-A1 | METAL COMPLEX, POLYMER COMPOUND, AND DEVICE CONTAINING IT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-02-12 | — | — | US | disclosed |
| US-20090015139-A1 | Organic electroluminescence device | SUMITOMO CHEMICAL., CO., LTD. | 2009-01-15 | — | — | US | disclosed |
| US-20080274303-A1 | Polymer Compound and Polymer Light Emitting Device Using the Same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-11-06 | — | — | US | disclosed |
| EP-1932851-A1 | METAL COMPLEX, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING DEVICE | Sumitomo Chemical Company, Limited (JP) | 2008-06-18 | — | — | EP | disclosed |
| US-20070154732-A1 | Dendrimer compound and organic luminescent device employing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-07-05 | — | — | US | disclosed |
| US-7157154-B2 | Organoboron polymers; photoconductivity; inks; thin films; semiconductors; surface light sources; dot matrix displays | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-01-02 | — | — | US | disclosed |
| EP-1724294-A1 | POLYMER AND POLYMERIC LUMINESCENT ELEMENT COMPRISING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2006-11-22 | — | — | EP | disclosed |
| US-20050170202-A1 | Polymer and polymeric luminescent element comprising the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190135852-A1 | METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACID | RNGTT, POLR2H, POLR2E | TSHR 551/4885THRB 1506/4885EPHX1 2751/4885 |
| US-10854818-B2 | Dendrimer compound and organic luminescent device employing the same | DCUN1D4, DCUN1D1, FLOT1 | TSHR 3807/4885THRB 3244/4885EPHX1 3770/4885 |
| US-20090043064-A1 | METAL COMPLEX, POLYMER COMPOUND, AND DEVICE CONTAINING IT | TIMCC, AP1M1, TXN | TSHR 3303/4885THRB 4163/4885EPHX1 3617/4885 |
| US-10730904-B2 | Method for liquid-phase synthesis of nucleic acid | RNGTT, POLR2H, POLR2E | TSHR 411/4885THRB 1249/4885EPHX1 2124/4885 |
| US-20180138413-A1 | DENDRIMER COMPOUND AND ORGANIC LUMINESCENT DEVICE EMPLOYING THE SAME | DCUN1D4, DCUN1D1, FLOT1 | TSHR 3807/4885THRB 3244/4885EPHX1 3770/4885 |
| US-20100019669-A1 | METAL COMPLEX, POLYMER COMPOUND AND DEVICE CONTAINING THOSE | AP1M1, MRPL21, C1R | TSHR 446/4885THRB 2848/4885EPHX1 3978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.